Clinical Trial Update: Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's Disease

View source ↗

Summary

This clinical trial update describes a prospective study quantifying phosphorylated alpha-synuclein in skin biopsies as a potential biomarker for Parkinson's di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Rem Sleep Behavior Disorder

Snippet

Sponsor: CND Life Sciences | Conditions: REM Behavior Disorder, Parkinson Disease | Status: ACTIVE_NOT_RECRUITING